ADC Therapeutics SA
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $249.2M | $262.8M |
| FY2018 | — | $126.2M | $138.8M |
| FY2019 | $0 | $111.2M | $115.6M |
| FY2020 | $34.8M | $335.5M | $439.2M |
| FY2021 | $87.2M | $154.0M | $466.5M |
| FY2022 | — | $79.5M | $326.4M |
| FY2023 | — | $-148.2M | $278.6M |
| FY2024 | — | $-202.6M | $250.9M |
| FY2025 | — | $-185.8M | $261.3M |